I disagree. Spinning off AMP Capital would suit the likes of Blackrock (are you one of them? but not AMP share holders, at least not in the long term. Capital is a quiet monster and it is roaring to life at ~$202b AUM and growing strongly. Funds under management growth appears to be accelerating and the company has flagged an increase in expected fees as a result (in the near future). Selling now would be disingenuous.
There were a number of subtle positive signs coming from the wealth arm which i believe confirm even it has turned the corner. Bank has been investing in scaling technology and with more money (Life sale) i expect it to grow strongly as well.
Combine the three and i expect each to be firing on all cylinders full steam ahead in the coming 6 months. And in 18 months time i expect AMP to be talked about again in a very different and positive manner.
One doesn't sell their profitable stocks and buy their losing stocks. Just as one doesn't do that with strong/weak business arms either.
- Forums
- ASX - By Stock
- 3 into 1 does not work?
I disagree. Spinning off AMP Capital would suit the likes of...
Featured News
Add AMP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.10 |
Change
0.003(0.23%) |
Mkt cap ! $2.948B |
Open | High | Low | Value | Volume |
$1.10 | $1.11 | $1.10 | $632.7K | 575.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 161251 | $1.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 30087 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 161251 | 1.095 |
18 | 245158 | 1.090 |
16 | 224864 | 1.085 |
10 | 161648 | 1.080 |
9 | 167652 | 1.075 |
Price($) | Vol. | No. |
---|---|---|
1.100 | 28551 | 13 |
1.105 | 113028 | 18 |
1.110 | 392816 | 24 |
1.115 | 333411 | 20 |
1.120 | 326984 | 21 |
Last trade - 10.19am 07/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.10 |
  |
Change
0.003 ( 0.69 %) |
|||
Open | High | Low | Volume | ||
$1.10 | $1.10 | $1.10 | 137579 | ||
Last updated 10.40am 07/05/2024 ? |
Featured News
AMP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online